why choose us

Clinical Trials Search

Showing 8,960 of 132,366 result(s)
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Status: Completed

Condition: Triple Negative Breast Cancer

Interventions: Intratumoral injection

Date: 2023-08-15

Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder

Status: Completed

Condition: Opioid Use Disorder

Interventions: The proposed study is a double-blind, controlled investigation of the effect of 1 high-dose psilocybin (30 mg) session compared to a very low dose ses

Date: 2023-08-15

Evaluating the Unmet Needs of Older Adults to Promote Functional Recovery After a Critical Illness

Status: NOT_YET_RECRUITING

Condition: Critical Illness

Interventions:

Date: 2023-08-15

Umbrella Study for Analysis of Data Related to Patients With Cancer

Status: Completed

Condition: Cancer

Interventions:

Date: 2023-08-15

Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata

Status: Completed

Condition: Alopecia Areata

Interventions: Subcutaneous administration of ADX-914

Date: 2023-08-15

A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)

Status: Completed

Condition: Oligometastatic Renal Cell Carcinoma

Interventions: Given by vein (IV)

Date: 2023-08-15

First in Human Study of TORL-4-500 in Participants With Advanced Cancer

Status: Completed

Condition: Advanced Solid Tumor

Interventions: antibody drug conjugate

Date: 2023-08-15

SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases

Status: Completed

Condition: Inflammatory Bowel Diseases

Interventions: One-on-one stress management and resilience consultation by a certified SMART trainer followed by self-guided on-line training consisting of 4 modules

Date: 2023-08-15

Biological Effects of Quercetin in COPD Phase II

Status: NOT_YET_RECRUITING

Condition: Chronic Obstructive Pulmonary Disease

Interventions: Placebo

Date: 2023-08-15